Frailty and Somatic Comorbidity in Older Patients With Medically Unexplained Symptoms

Autor: Peter Lucassen, Linda de Jonge, Peter H. Hilderink, Carolien E. M. Benraad, Denise Hanssen, Richard C. Oude Voshaar, Paul Naarding, M. Arts
Přispěvatelé: Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE), Clinical Cognitive Neuropsychiatry Research Program (CCNP)
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
SOMATOFORM DISORDERS
0302 clinical medicine
Quality of life
Weight loss
QUALITY-OF-LIFE
LEUKOCYTE TELOMERE LENGTH
Health care
ANXIETY
030212 general & internal medicine
General Nursing
medically unexplained
Aged
80 and over

Frailty
Health Policy
MUS
SOMATIZATION
General Medicine
PREVALENCE
comorbidity
MES
Anxiety
Female
HEALTH
medicine.symptom
medicine.medical_specialty
animal structures
Frail Elderly
Affect (psychology)
VALIDATION
Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]
03 medical and health sciences
All institutes and research themes of the Radboud University Medical Center
DSM-IV
Internal medicine
medicine
Humans
Aged
Primary Health Care
business.industry
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
Medically unexplained
medicine.disease
Comorbidity
INTERVIEW
Cross-Sectional Studies
Medically Unexplained Symptoms
Self Report
Geriatrics and Gerontology
business
Somatization
030217 neurology & neurosurgery
Zdroj: Journal of the American Medical Directors Association, 20, 1150-1155
Journal of the American Medical Directors Association, 20, 9, pp. 1150-1155
Journal of the American Medical Directors Association, 20(9), 1150-1155. ELSEVIER SCIENCE INC
ISSN: 1525-8610
Popis: Objectives: To examine the level of frailty and somatic comorbidity in older patients with medically unexplained symptoms (MUS) and compare this to patients with medically explained symptoms (MES). Design: Cross-sectional, comparative study.Design: Cross-sectional, comparative study.Setting: Community, primary care, and secondary healthcare to recruit patients with MUS in various developmental and severity stages and primary care to recruit patients with MES.Participants: In total, 118 patients with MUS and 154 patients with MES, all aged >60 years.Methods: Frailty was assessed according to the Fried criteria (gait speed, handgrip strength, unintentional weight loss, exhaustion, and low physical activity), somatic comorbidity according to the self-report Charlson comorbidity index, and the number of prescribed medications.Results: Although patients with MUS had less physical comorbidity compared with patients with MES, they were prescribed the same number of medications. Moreover, patients with MUS were more often frail compared with patients with MES. Among patients with MUS, physical frailty was associated with the severity of unexplained symptoms, the level of hypochondriacal beliefs, and the level of somatisation.Conclusions and implications: Despite a lower prevalence of overt somatic diseases, patients with MUS are more frail compared with older patients with MES. These results suggest that at least in some patients age-related phenomena might be erroneously classified as MUS, which may affect treatment strategy. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Databáze: OpenAIRE